Minimally Invasive Non-surgical Therapy With or Without Injectable Bone Putty
NCT ID: NCT06553222
Last Updated: 2024-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE3
30 participants
INTERVENTIONAL
2024-11-04
2025-12-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of Injectable Alb-PRF in the Management of Intrabony Defect in Stage-III Periodontitis Patients
NCT06297577
The Present Study Was Performed to Evaluate the Efficacy of Lyophilized-PRF in Treatment of Periodontal Intra-bony Defects
NCT06625528
The Effect of A-PRF+ Versus Open Flap Debridement in the Treatment of Patients With Stage III Periodontitis
NCT03924336
Clinical and Radiographic Evaluation of Using the Entire Papilla Preservation Technique With and Without Autogenous Bone Graft and Injectable Platelet Rich Fibrin in Treatment of Periodontal Intraosseous Defects
NCT06347263
Evaluation of Autogenous Demineralized Dentin Graft Vs Autogenous Bone Graft in Management of Intrabony Defects
NCT06048042
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study has bee approved by the ethical committee, Faculty of Dental medicine, Al-Azhar University, Assiut branch.
2\. All patients will be fully informed about the study's nature and the possible risks of the study procedures; they sign the consent form before the work.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional
Participants receives Injectable bone putty - Minimally invasive debridement periodontal flap plus putty bone graft in three osseous wall defect
Putty bone - Tricalcium phosphate with Collagen gel
Minimally invasive debridement periodontal flap and Bone graft placement to augment the lost alveolar bone
Control group
\- Participants receive No graft (No drug) Minimally invasive debridement periodontal flap
Putty bone - Tricalcium phosphate with Collagen gel
Minimally invasive debridement periodontal flap and Bone graft placement to augment the lost alveolar bone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Putty bone - Tricalcium phosphate with Collagen gel
Minimally invasive debridement periodontal flap and Bone graft placement to augment the lost alveolar bone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2- or 3-wall intra-bony interproximal defect with depth ≥3 mm, a width of ≥3 mm at its most coronal part and 45-55-degree angulation will be selected in order to reduce defect variability
* All patients will be free from any systemic diseases according to the American Dental Academy general guidelines for referring dental patients to specialists and other care settings.
Exclusion Criteria
35 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hagar Ahmed Saad
Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUAREC20240007-5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.